beryllium has been researched along with Neuroblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akudugu, JM; Binder, A; Böhm, L; Giese, A; Serafin, A; Slabbert, J | 1 |
| Bakker, AV; Faraci, WS; Jackson, E; Pratt, K; Zorn, SH | 1 |
2 other study(ies) available for beryllium and Neuroblastoma
| Article | Year |
|---|---|
Changes in G1-phase populations in human glioblastoma and neuroblastoma cell lines influence p66/Be neutron-induced micronucleus yield.
Topics: Beryllium; Cell Line, Tumor; Cell Survival; Flow Cytometry; G1 Phase; Glioblastoma; Humans; Linear Energy Transfer; Micronuclei, Chromosome-Defective; Micronucleus Tests; Neuroblastoma; Neutrons; Photons; Radiation Tolerance; Time Factors | 2004 |
Beryllium competitively inhibits brain myo-inositol monophosphatase, but unlike lithium does not enhance agonist-induced inositol phosphate accumulation.
Topics: Animals; Beryllium; Binding, Competitive; Brain; Cattle; Humans; Hydrolysis; Inositol; Inositol Phosphates; Kinetics; Lithium; Neuroblastoma; Phosphoric Monoester Hydrolases; Rats; Tumor Cells, Cultured | 1993 |